Aisling Capital as of Dec. 31, 2018
Portfolio Holdings for Aisling Capital
Aisling Capital holds 9 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 80.9 | $286M | 2.0M | 140.07 | |
| Aimmune Therapeutics | 13.5 | $48M | 2.0M | 23.92 | |
| Adma Biologics (ADMA) | 2.4 | $8.6M | 3.6M | 2.39 | |
| Transenterix | 1.5 | $5.4M | 2.4M | 2.26 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.7 | $2.4M | 1.0M | 2.35 | |
| Viewray (VRAYQ) | 0.6 | $2.2M | 364k | 6.07 | |
| Chimerix (CMRX) | 0.3 | $1.2M | 473k | 2.57 | |
| Pernix Therapeutics Holdings | 0.0 | $88k | 210k | 0.42 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.0 | $25k | 2.5M | 0.01 |
